Literature DB >> 11991333

Acquired immunodeficiency syndrome in older African Americans.

Allen S Funnyé1, Abbasi J Akhtar, Gisele Biamby.   

Abstract

The purpose of this study was to determine if older African Americans are disproportionately affected by acquired immunodeficiency syndrome (AIDS), and to review the clinical impact of AIDS and the importance of prevention and treatment efforts. A review of the literature and statistics was obtained using Medline and the AIDS Public Information Data Set offered by the Centers for Disease Control and Prevention. Twenty-seven percent of the U.S. population is above the age of 50, and the number of AIDS cases in this group is growing, with African Americans accounting for the highest proportion of cases and deaths. Testing for HIV may be delayed and symptoms attributed to other illnesses. Though 5% of new cases occur in those over 50, prevention programs, testing, and the perception of risk by providers may be insufficient. There are few research studies on HIV treatment in older patients and no specific guidelines for antiretroviral treatments available. Although death rates for AIDS has been declining, adults over 50 still have the highest mortality rate. Co-morbid conditions, such as heart disease and hypertension, may require taking multiple drugs, which may complicate treatment. Increasing heterosexual transmission rates and a lack of information on HIV reinforces the need for specific prevention programs targeted toward older African Americans.

Entities:  

Mesh:

Year:  2002        PMID: 11991333      PMCID: PMC2594233     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  20 in total

1.  HIV testing behaviors and attitudes regarding HIV/AIDS of adults aged 50-64.

Authors:  K A Mack; S D Bland
Journal:  Gerontologist       Date:  1999-12

2.  AIDS in older people.

Authors:  M Terpenning
Journal:  J Am Geriatr Soc       Date:  1998-02       Impact factor: 5.562

3.  AIDS among persons aged > or = 50 years--United States, 1991-1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-01-23       Impact factor: 17.586

Review 4.  Older adults and HIV.

Authors:  L W Moore; L B Amburgey
Journal:  AORN J       Date:  2000-04       Impact factor: 0.676

5.  Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997.

Authors:  S Whitman; J Murphy; M Cohen; R Sherer
Journal:  Arch Intern Med       Date:  2000-02-14

6.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

Review 7.  HIV in older Americans: an epidemiologic perspective.

Authors:  R Lieberman
Journal:  J Midwifery Womens Health       Date:  2000 Mar-Apr       Impact factor: 2.388

8.  The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study.

Authors:  D J Skiest; E Rubinstien; N Carley; L Gioiella; R Lyons
Journal:  Am J Med       Date:  1996-12       Impact factor: 4.965

9.  The changing epidemiology of human immunodeficiency virus infection in older persons.

Authors:  S M Gordon; S Thompson
Journal:  J Am Geriatr Soc       Date:  1995-01       Impact factor: 5.562

10.  Effect of older age on survival in human immunodeficiency virus (HIV) disease.

Authors:  J N Martin; J M Colford; L Ngo; I B Tager
Journal:  Am J Epidemiol       Date:  1995-12-01       Impact factor: 4.897

View more
  2 in total

1.  Sexual diversity and HIV risk among older heterosexual African American males who are seropositive.

Authors:  Christopher Lance Coleman; Katherine Ball
Journal:  Appl Nurs Res       Date:  2009-01-15       Impact factor: 2.257

2.  Jaundice in African-American and Hispanic patients with AIDS.

Authors:  Abbasi J Akhtar; Magda Shaheen
Journal:  J Natl Med Assoc       Date:  2007-12       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.